Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda M Griffith

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Multiple Sclerosis and Related Disorders|July 20, 2021
Brain volume change after high-dose immunosuppression and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosisHyunwoo Lee, Kunio Nakamura, Sridar Narayanan, et al.
The Journal of Allergy and Clinical Immunology|December 3, 2013
Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experienceWilliam T Shearer, Elizabeth Dunn, Luigi D Notarangelo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 9, 2017
Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCTJennifer Heimall, Rebecca H Buckley, Jennifer Puck, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 23, 2010
Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studiesMarcelo C Pasquini, Linda M Griffith, Douglas L Arnold, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 4, 2015
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group ReportSophie Paczesny, Frances T Hakim, Joseph Pidala, et al.
Neurology|February 3, 2017
High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MSRichard A Nash, George J Hutton, Michael K Racke, et al.
The Journal of Allergy and Clinical Immunology|December 17, 2009
Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and managementLinda M Griffith, Morton J Cowan, Luigi D Notarangelo, et al.
The Journal of Allergy and Clinical Immunology|November 11, 2008
Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needsLinda M Griffith, Morton J Cowan, Donald B Kohn, et al.
JAMA Neurology|December 30, 2014
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim reportRichard A Nash, George J Hutton, Michael K Racke, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2012
Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant ResearchMarcelo C Pasquini, Julio Voltarelli, Harold L Atkins, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Multiple Sclerosis and Related Disorders|July 20, 2021
Brain volume change after high-dose immunosuppression and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosisHyunwoo Lee, Kunio Nakamura, Sridar Narayanan, et al.
The Journal of Allergy and Clinical Immunology|December 3, 2013
Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experienceWilliam T Shearer, Elizabeth Dunn, Luigi D Notarangelo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 9, 2017
Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCTJennifer Heimall, Rebecca H Buckley, Jennifer Puck, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 23, 2010
Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studiesMarcelo C Pasquini, Linda M Griffith, Douglas L Arnold, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 4, 2015
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group ReportSophie Paczesny, Frances T Hakim, Joseph Pidala, et al.
Neurology|February 3, 2017
High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MSRichard A Nash, George J Hutton, Michael K Racke, et al.
The Journal of Allergy and Clinical Immunology|December 17, 2009
Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and managementLinda M Griffith, Morton J Cowan, Luigi D Notarangelo, et al.
The Journal of Allergy and Clinical Immunology|November 11, 2008
Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needsLinda M Griffith, Morton J Cowan, Donald B Kohn, et al.
JAMA Neurology|December 30, 2014
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim reportRichard A Nash, George J Hutton, Michael K Racke, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2012
Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant ResearchMarcelo C Pasquini, Julio Voltarelli, Harold L Atkins, et al.
Pageof 6